0000950137-01-503802.txt : 20011009
0000950137-01-503802.hdr.sgml : 20011009
ACCESSION NUMBER: 0000950137-01-503802
CONFORMED SUBMISSION TYPE: 15-12G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20010928
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCUMED INTERNATIONAL INC
CENTRAL INDEX KEY: 0000888335
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 364054899
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 15-12G
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20652
FILM NUMBER: 1747979
BUSINESS ADDRESS:
STREET 1: 900 N FRANKLIN ST
STREET 2: STE 401
CITY: CHICAGO
STATE: IL
ZIP: 60610
BUSINESS PHONE: 3126429200
MAIL ADDRESS:
STREET 1: 920 N FRANKLIN STREET
STREET 2: SUITE 402
CITY: CHICAGO
STATE: IL
ZIP: 60610
FORMER COMPANY:
FORMER CONFORMED NAME: ALAMAR BIOSCIENCES INC
DATE OF NAME CHANGE: 19950504
15-12G
1
c65208e15-12g.txt
CERTIFICATION AND NOTICE OF TERMINATION
1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
FORM 15
----------------------
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
----------------------
Commission File Number: 0-20652
ACCUMED INTERNATIONAL, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
920 North Franklin Street, Suite 402, Chicago, Illinois 60610, (312)642-9200
--------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
Common Stock, par value $.01 per share
--------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
--------------------------------------------------------------------------------
(Title of all classes of securities for which a duty to file reports under
section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(i) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or notice
date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, AccuMed
International, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Date: September 27, 2001 ACCUMED INTERNATIONAL, INC.
By: /s/ Peter P. Gombrich
------------------------------
Peter P. Gombrich,
President